申请人:Burroughs Wellcome Co.
公开号:US04512992A1
公开(公告)日:1985-04-23
This application is directed to treatment of psoriasis with a pyrido pyrimidine compound such as 2,4-diamino-6-(3,4-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine.
这个应用程序是针对银屑病的治疗,使用吡啶嘧啶类化合物,例如2,4-二氨基-6-(3,4-二甲氧基苯基)-5-甲基吡啶[2,3-d]嘧啶。